Literature DB >> 8520732

Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases)

H Budka1, A Aguzzi, P Brown, J M Brucher, O Bugiani, J Collinge, H Diringer, F Gullotta, M Haltia, J J Hauw.   

Abstract

Despite many sensational and intimidating reports in the mass media, transmissible spongiform encephalopathies (prion disease) are not contagious in the usual sense. Successful transmission requires both specific material (an affected individual's tissue, from or adjacent to CNS) and specific modes (mainly penetrating contact with the recipient). Nevertheless, specific safety precautions are mandatory to avoid accidental transmission and to decontaminate any infectivity. Autopsy is essential for definite diagnosis of these disorders. Recommendations are given here for performance of the autopsy, for neuropathology service and appropriate decontamination; they are based on the current literature and on precautions taken in most laboratories with experience in handling tissue from transmissible spongiform encephalopathies. In particular, special care must be taken to avoid penetrating wounds, possible contamination should be kept to a minimum, and potential infectious material must be adequately decontaminated by specific means.

Entities:  

Mesh:

Year:  1995        PMID: 8520732     DOI: 10.1111/j.1750-3639.1995.tb00609.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  14 in total

1.  Sporadic Creutzfeldt-Jakob disease: a comparison of pathological findings and diffusion weighted imaging.

Authors:  Heike Russmann; Francois Vingerhoets; Judith Miklossy; Philippe Maeder; Markus Glatzel; Adriano Aguzzi; Julien Bogousslavsky
Journal:  J Neurol       Date:  2005-03-03       Impact factor: 4.849

Review 2.  Prion diseases: what will be next?

Authors:  P van der Valk
Journal:  J Clin Pathol       Date:  1998-04       Impact factor: 3.411

3.  Diagnosing Creutzfeldt-Jakob disease.

Authors:  R Will; M Zeidler
Journal:  BMJ       Date:  1996-10-05

4.  Branched polyamines cure prion-infected neuroblastoma cells.

Authors:  S Supattapone; H Wille; L Uyechi; J Safar; P Tremblay; F C Szoka; F E Cohen; S B Prusiner; M R Scott
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 5.  Prions: Beyond a Single Protein.

Authors:  Alvin S Das; Wen-Quan Zou
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

6.  Inactivation of prions by acidic sodium dodecyl sulfate.

Authors:  David Peretz; Surachai Supattapone; Kurt Giles; Julie Vergara; Yevgeniy Freyman; Pierre Lessard; Jiri G Safar; David V Glidden; Charles McCulloch; Hoang-Oanh B Nguyen; Michael Scott; Stephen J Dearmond; Stanley B Prusiner
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  Creutzfeldt-Jakob disease in Austria.

Authors:  J A Hainfellner; K Jellinger; H Diringer; M Guentchev; R Kleinert; P Pilz; H Maier; H Budka
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

8.  Public health issues and clinical and neurological characteristics of the new variant of Creutzfeldt-Jakob disease and other human and animal transmissible spongiform encephalopathies: memorandum from two WHO meetings.

Authors: 
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

9.  Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice.

Authors:  Jonathan D F Wadsworth; Susan Joiner; Jacqueline M Linehan; Melanie Desbruslais; Katie Fox; Sharon Cooper; Sabrina Cronier; Emmanuel A Asante; Simon Mead; Sebastian Brandner; Andrew F Hill; John Collinge
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-03       Impact factor: 11.205

10.  Heightened incidence of sporadic Creutzfeldt-Jakob disease is associated with a shift in clinicopathological profiles.

Authors:  Katharina Stoeck; Klaus Hess; Lorenz Amsler; Tobias Eckert; Dieter Zimmermann; Adriano Aguzzi; Markus Glatzel
Journal:  J Neurol       Date:  2008-10-29       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.